STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer
Stephanie Totten(Jewish General Hospital), Josie Ursini‐Siegel(Jewish General Hospital), Ryuhjin Ahn(Allen Institute), Michaël Pollak(Northwestern University), Nancy Santos Martínez(Jewish General Hospital), Ivan Topisirović(Jewish General Hospital), Valérie Sabourin(Jewish General Hospital), Alice Quynh Huong Nguyen(Jewish General Hospital), Adriana Aguilar‐Mahecha(Jewish General Hospital), Kevin Petrecca(Montreal Neurological Institute and Hospital), Eduardo Cepeda Cañedo(Jewish General Hospital), Paul Savage(Unknown), Claudia L. Kleinman(Columbia University Irving Medical Center), Ouafa Najyb(McGill University Health Centre), Kyle Lewis(Jewish General Hospital), Young Kyuen Im(Jewish General Hospital), Julie St‐Pierre(University of Ottawa), Daina Avizonis(McGill University Health Centre), Mark Basik(Jewish General Hospital), Hellen Kuasne(McGill University Health Centre), Rachel La Selva(Jewish General Hospital), Michael Witcher(McGill University), Marie-Line Goulet(McGill University), Steven Hébert(Yale University), Peter M. Siegel(L'Oréal (France)), Benjamin Lebeau(Jewish General Hospital), Matthew Dankner(McGill University), Morag Park(Goodman (Japan)), Rongtuan Lin(McGill University), Catherine Chabot, Constanza Martínez(McGill University Health Centre)
Cited by 61
Related Papers
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
|The Lancet|1998|1.8k
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
|Cancer Cell|2006|1.6k
Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
|Cell|1993|1.1k
Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells
|Cancer Research|2006|1k